1. Home
  2. TV vs VIR Comparison

TV vs VIR Comparison

Compare TV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TV

Grupo Televisa S.A.

HOLD

Current Price

$2.38

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.81

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TV
VIR
Founded
1969
2016
Country
Mexico
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
TV
VIR
Price
$2.38
$10.81
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$5.30
$19.43
AVG Volume (30 Days)
981.0K
1.8M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
N/A
$270.22
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$4.75
52 Week High
$3.49
$11.94

Technical Indicators

Market Signals
Indicator
TV
VIR
Relative Strength Index (RSI) 29.44 55.77
Support Level N/A $8.43
Resistance Level $2.91 $10.91
Average True Range (ATR) 0.10 0.67
MACD -0.03 0.04
Stochastic Oscillator 19.66 59.86

Price Performance

Historical Comparison
TV
VIR

About TV Grupo Televisa S.A.

Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: